WuXi Biologics (2269)

49.05
+0.15(+0.31%)
  • Volume:
    22,392,881
  • Bid/Ask:
    49.05/49.10
  • Day's Range:
    47.40 - 50.50

2269 Overview

Prev. Close
48.9
Day's Range
47.4-50.5
Revenue
15.27B
Open
48.95
52 wk Range
35-87
EPS
1.06
Volume
22,392,881
Market Cap
207.42B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
27,583,620
P/E Ratio
40.90
Beta
1.13
1-Year Change
-19.81%
Shares Outstanding
4,228,671,019
Next Earnings Date
-
What is your sentiment on WuXi Biologics?
or
Market is currently closed. Voting is open during market hours.

WuXi Biologics Company Profile

WuXi Biologics Company Profile

Employees
10593
Market
Hong Kong

WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing services of biologics. Through fully-integrated biologics Contract Research, Development and Manufacturing Organization (CRDMO), the Company provides one-stop end-to-end biologics services. Biologics development process stages include pre-IND (drug discovery and pre-clinical development), early-phase (phases I & II) clinical development, late-phase (phase III) clinical development and commercial manufacturing. The Company also offers end-to-end vaccine CRDMO services, including vaccine discovery and development, scale-up commercial manufacturing and global distribution. The Company has WuXiBody bispecific antibody platform, SDArBodY multispecific antibody platform, WuXia cell line development platform, WuXiUP continuous manufacturing platform and mRNA vaccine platform. The Company mainly operates its businesses in the domestic and overseas markets.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell